Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Biosimilars offer clinically effective treatment alternatives to ...
Another clear sign that the US biosimilars market is off to a good start appeared on Monday, with staff of the US Food and Drug Administration (FDA) concluding that Sandoz’s biosimilar, known ...
There’s a new medicine that puts your painful, crippling diseasein remission and lets you lead a normal life. Thousands of patientsbefore you have benefited from this miracle of modern medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results